Cargando…

Correction: Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5(+) colorectal cancer

Detalles Bibliográficos
Autores principales:	Feng, Haoran, Liu, Kun, Shen, Xiaonan, Liang, Juyong, Wang, Changgang, Qiu, Weihua, Cheng, Xi, Zhao, Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683607/ https://www.ncbi.nlm.nih.gov/pubmed/33230188 http://dx.doi.org/10.1038/s41419-020-03208-z

Ejemplares similares

Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5(+) colorectal cancer
por: Feng, Haoran, et al.
Publicado: (2020)

ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer
por: Shen, Xiaonan, et al.
Publicado: (2022)

Correction to: Long‑term quality of life after ETV or ETV with consecutive VP shunt placement in hydrocephalic pediatric patients
por: Bogaczyk, Victoria, et al.
Publicado: (2022)

Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer
por: Gorbunova, Vera, et al.
Publicado: (2019)

Correction: Ret and Etv4 Promote Directed Movements of Progenitor Cells during Renal Branching Morphogenesis
Publicado: (2016)

Potential Therapeutic Targets of B7 Family in Colorectal Cancer
por: Wang, Changgang, et al.
Publicado: (2020)

Correction to: A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
por: Guo, Chunmei, et al.
Publicado: (2021)

Correction to: Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
por: Wang, Dan, et al.
Publicado: (2021)

Correction to: SB8: A Bevacizumab Biosimilar
por: Syed, Yahiya Y.
Publicado: (2020)

Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways
por: Greening, David W., et al.
Publicado: (2016)

Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
por: Wagner, Steve, et al.
Publicado: (2019)

Correction: Inhibitory Activity of Bevacizumab to Differentiation of Retinoblastoma Cells
por: Heo, Jang Won, et al.
Publicado: (2012)

Correction to: MYL-1402O: A Bevacizumab Biosimilar
por: Lee, Arnold
Publicado: (2022)

Correction: Tag SNP Polymorphism of CCL2 and Its Role in Clinical Tuberculosis in Han Chinese Pediatric Population
por: Feng, Wei-Xing, et al.
Publicado: (2011)

Correction: Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6
por: Li, Jingyi, et al.
Publicado: (2018)

Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
por: Zhang, Tao, et al.
Publicado: (2021)

Correction: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
por: Zhang, Tao, et al.
Publicado: (2023)

Correction to: CCL3 contributes to secondary damage after spinal cord injury
por: Pelisch, Nicolas, et al.
Publicado: (2021)

Correction to: EGFR/Ras-induced CCL20 production modulates the tumour microenvironment
por: Hippe, Andreas, et al.
Publicado: (2021)

Author Correction: In vivo transduction of ETV2 improves cardiac function and induces vascular regeneration following myocardial infarction
por: Lee, Sunghun, et al.
Publicado: (2019)

Publisher Correction: Environmental eustress modulates β-ARs/CCL2 axis to induce anti-tumor immunity and sensitize immunotherapy against liver cancer in mice
por: Liu, Chaobao, et al.
Publicado: (2021)

Correction: Reconstruction of lossless molecular representations from fingerprints
por: Ucak, Umit V., et al.
Publicado: (2023)

Correction to: Multiple levers for overcoming the recalcitrance of lignocellulosic biomass
por: Holwerda, Evert K., et al.
Publicado: (2019)

Correction: RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration
por: Datar, Ila, et al.
Publicado: (2016)

Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression
por: Feng, Haoran, et al.
Publicado: (2020)

Correction to: Small extracellular vesicles encapsulating CCL2 from activated astrocytes induce microglial activation and neuronal apoptosis after traumatic spinal cord injury
por: Rong, Yuluo, et al.
Publicado: (2021)

CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species
por: Fu, Zhiping, et al.
Publicado: (2018)

Correction: Improving the quality of chemical language model outcomes with atom-in-SMILES tokenization
por: Ucak, Umit V., et al.
Publicado: (2023)

The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progression
por: Peng, Yi, et al.
Publicado: (2021)

Correction: Evaluation of CCL21 role in post-knee injury inflammation and early cartilage degeneration
por: Mohan, Subburaman, et al.
Publicado: (2021)

Correction: Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization
Publicado: (2022)

Author Correction: Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab
por: Matsumoto, Toshihiko, et al.
Publicado: (2023)

Common genetic variation in ETV6 is associated with colorectal cancer susceptibility
por: Wang, Meilin, et al.
Publicado: (2016)

Correction: Overcoming Stagnation in the Levels and Distribution of Child Mortality: The Case of the Philippines
por: Bermejo, Raoul, et al.
Publicado: (2015)

Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy
por: Kiaie, Seyed Hossein, et al.
Publicado: (2023)

Correction to: Cost-Effectiveness Analysis of Olaparib in Combination with Bevacizumab Compared with Bevacizumab Monotherapy for the First-Line Maintenance Treatment of Homologous Recombination Deficiency-Positive Advanced Ovarian Cancer
por: Elsea, David, et al.
Publicado: (2022)

Correction: Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis
por: Izhak, Liat, et al.
Publicado: (2018)

Correction to: Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer
por: Yu, Yuchong, et al.
Publicado: (2023)

Correction to: Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer
por: Yu, Yuchong, et al.
Publicado: (2023)

Correction: Homogeneous and heterogeneous risk and prognostic factors for lung metastasis in colorectal cancer patients
por: Wang, Hongmei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dq1erk34nos9a44gf8o4bo1sbi